Drugs News and Research

RSS

Report released on pharmaceutical mail-back pilot program funded by EPA

Through a grant awarded by the U.S. Environmental Protection Agency (EPA), the University of Maine’s Center on Aging has completed the first statewide mail-back pilot program for managing pharmaceutical waste from consumers.

18 May 2010

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a new agreement with Medico's Hirata for distribution of its VerifyNow System in Japan.

18 May 2010

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.

18 May 2010

International Stem Cell announces strategic alliance with TAP

International Stem Cell Corporation, www.intlstemcell.com, announced today that it had entered into a strategic alliance with The Automation Partnership, www.automationpartnership.com, to automate and scale up the production of stem cell-derived human corneal tissue.

18 May 2010

Web conference to analyze latest trends, developments in the European melanoma skin cancer market

There are only two FDA/EMEA approved drugs currently available for treating advanced melanoma. The available drugs, however, are not completely effective and have adverse effects. Unmet needs of patients, especially those with advanced melanoma are therefore quite high and have led to a low drug adoption and market growth over the years. The future looks brighter though, with a few promising drugs in pipeline for advanced melanoma.

18 May 2010

Ion Torrent chairman and CEO named 2010 winner of Connecticut Medal of Technology

Dr. Jonathan M. Rothberg, chairman, CEO and founder of Guilford-based Ion Torrent, has been named the 2010 winner of the Connecticut Medal of Technology for his development of innovative genomic technology.

18 May 2010

KemPharm enters Supply Agreement with Johnson Matthey for KP201 hydrocodone prodrug for acute pain

KemPharm, Inc. today announced that it has entered into an exclusive Supply Agreement with Johnson Matthey Inc., for the manufacture of the active pharmaceutical ingredient (API), KP201, KemPharm's novel hydrocodone prodrug for acute pain. KP201 was identified utilizing KemPharm's proprietary ligand activated therapy (LAT) approach.

18 May 2010

China Sky One Medical first-quarter total revenues increase 16.4% to $28.9 million

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced record financial results for the first quarter of 2010. Management is working diligently to finalize the amended Annual Report on Form 10-K for 2009.

18 May 2010

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).

18 May 2010

Combination therapy proves to be effective treatment for lethal form of leukemia: Research

New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the new therapeutic strategy effectively targets notoriously intractable leukemia stem cells that often escape standard treatment and are a main factor in disease relapse.

18 May 2010

Cancer Research UK launches new cancer centre in Leeds

LEEDS today joins a unique chain of Cancer Research UK Centres that are being launched across the UK.

18 May 2010

Combining medicine switch with cognitive behavioral therapy can reduce symptoms of depression: Study

More than one-third of teenagers with treatment-resistant depression - many of whom had been depressed for more than two years - became symptom-free six months after switching their medication or combining a medicine switch with cognitive behavioral therapy during a multicenter study led by UT Southwestern Medical Center researchers.

18 May 2010

China Nepstar Chain Drugstore first-quarter revenue increases 12.1% to $83 million

China Nepstar Chain Drugstore Ltd., the largest drugstore chain in China in terms of the number of directly operated stores, with 2,559 directly operated stores in operation as of March 31, 2010, today announced its unaudited financial results for the first quarter ended March 31, 2010.

18 May 2010

Pfizer, Washington University announce indications discovery collaboration

In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.

18 May 2010

University of Leeds researchers identify natural defence mechanism against heart disease

A natural defence mechanism against heart disease could be switched on by steroids sold as health supplements, according to researchers at the University of Leeds.

18 May 2010

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

Sigma-Tau Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the company's new drug application (NDA) for its cysteamine hydrochloride ophthalmic solution, an investigational therapy for the treatment of corneal cystine crystals in patients with cystinosis. The FDA also granted the NDA Priority Review status, a designation given to drugs that may provide major advances or a treatment where no adequate therapy exists.

18 May 2010

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

Researchers will be exploring whether a new, very low cost, one-a-day combined 'polypill' could reduce the risk of heart attacks, strokes and other cardiovascular problems across the world, in a major new international trial that launches today.

18 May 2010

High-fat ketogenic diet effective in treating infantile spasms

The high-fat ketogenic diet can dramatically reduce or completely eliminate debilitating seizures in most children with infantile spasms, whose seizures persist despite medication, according to a Johns Hopkins Children's Center study published online April 30 in the journal Epilepsia.

18 May 2010

MorphoSys AG (DE) - AbD Serotec enters new growth area

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its research and diagnostic antibody unit AbD Serotec is active in a new growth area.

18 May 2010

Five-day World Health Assembly meeting kicks off in Geneva

The annual meeting of the World Health Assembly (WHA) convened on Monday in Geneva, Switzerland, Deutsche Presse-Agentur/Monsters and Critics.com reports. According to the news service, influenza vaccines, the fight against tuberculosis, intellectual property and reducing counterfeit drugs will be discussed (4/17).

18 May 2010

Drugs News and Research

Report released on pharmaceutical mail-back pilot program funded by EPA

Medico's Hirata to distribute Accumetrics' VerifyNow System in Japan

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

International Stem Cell announces strategic alliance with TAP

Web conference to analyze latest trends, developments in the European melanoma skin cancer market

Ion Torrent chairman and CEO named 2010 winner of Connecticut Medal of Technology

KemPharm enters Supply Agreement with Johnson Matthey for KP201 hydrocodone prodrug for acute pain

China Sky One Medical first-quarter total revenues increase 16.4% to $28.9 million

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Combination therapy proves to be effective treatment for lethal form of leukemia: Research

Cancer Research UK launches new cancer centre in Leeds

Combining medicine switch with cognitive behavioral therapy can reduce symptoms of depression: Study

China Nepstar Chain Drugstore first-quarter revenue increases 12.1% to $83 million

Pfizer, Washington University announce indications discovery collaboration

University of Leeds researchers identify natural defence mechanism against heart disease

FDA accepts for filing Sigma-Tau Pharmaceuticals' cysteamine hydrochloride ophthalmic solution NDA

UMPIRE trial of Red Heart Pill launched to combat cardiovascular problems

High-fat ketogenic diet effective in treating infantile spasms

MorphoSys AG (DE) - AbD Serotec enters new growth area

Five-day World Health Assembly meeting kicks off in Geneva

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News